Onteveros, Ziv Kaiser D.
HRN: 11-33-37 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/05/2024
CEFUROXIME 750MG (VIAL)
08/05/2024
08/12/2024
IV
750mg
Q8
Multiple Abrasion
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes